Biofrontera Inc.
BFRI

$7.45 M
Marketcap
$0.81
Share price
Country
$-0.02
Change (1 day)
$2.22
Year High
$0.65
Year Low

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

etoro

Biofrontera Inc. (BFRI) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2024 5.32 M -983,000 17.67 M 22.1 M 20.7 M
2023 5.16 M 4.06 M 23.14 M 27.93 M 23.08 M
2022 7.41 M -15,862,000 27.01 M 50.88 M 43.14 M
2021 3.78 M -24,545,000 41.88 M 53.22 M 46.42 M
2020 3.29 M -8,080,000 18.31 M 24.14 M 19.58 M